(202) 599-8435

FDA Calls for Improved Access to Medication-Assisted Treatment (MAT)

Posted on Dec 14, 2017
By :

The U.S. Food & Drug Administration (FDA) has called for improved access to medication-assisted treatment (MAT). FDA recently approved a once-monthly buprenorphine injection to treat opioid dependence and addiction, yet many people cannot access all FDA-approved treatment options due to coverage limitations of public and private health insurance. Read more here.

Print Friendly, PDF & Email
About the Author